Q-SCORE
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Apr 2025)
What this means for you
This application is over — abandoned 14 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97050710
- Mark type
- Stylized text
- Filed
- 29 Sept 2021
- Published for opposition
- 16 Jul 2024
- Abandoned
- 14 Apr 2025
- Attorney of record
- Nigamnarayan Acharya
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing kits comprised of medical diagnostic reagents and assays for testing body fluids for use in disease detection, namely, kidney disease; diagnostic testing kits comprised of medical diagnostic reagents and assays for kidney transplant surveillance, namely, monitoring kidney function, damage, rejection, or tolerance
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic testing, monitoring and reporting services, all for the treatment of kidney disease; medical screening services in the field of kidney disease; providing medical information regarding kidney disease; providing medical information in the field of nephrology
Owner
- NephroSant, Inc., Brisbane, CA, US
- NephroSant, Inc., Brisbane, CA, US
Prosecution history
- 14 Apr 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Apr 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 26 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jun 2024 — EXAMINER'S AMENDMENT ENTERED
- 13 Jun 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Jun 2024 — EXAMINERS AMENDMENT E-MAILED
- 13 Jun 2024 — EXAMINERS AMENDMENT -WRITTEN
- 16 May 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 16 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED